James Brodsky, MD
Orthopaedic Surgery · Dallas, TXNPI 1740270206
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,444,833 of the $2,531,170 with a category attached, or 96.6%. Smith+Nephew accounts for 75.6% of it on its own, with 7 other manufacturers making up the rest. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $26,644 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1.9M
- Integra Lifesciences Corporation$585K
- Stryker$31K
- Ascension Orthopedics, Inc.$1K
- Restor3d, Inc.$207
- Zimmer Biomet$22
- plus $32 from 2 others
What the payments were for
- Royalty or licence$2,444,83397%
- Consulting fees$71,9103%
- Speaking & faculty fees$12,3830%
- Travel & lodging$1,1750%
- Food & beverage$8680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 36 | $1,913,885 |
| Integra Lifesciences Corporation | 44 | $584,504 |
| Stryker(2 entities) | 10 | $31,269 |
| Ascension Orthopedics, Inc. | 1 | $1,250 |
| Restor3d, Inc. | 1 | $207 |
| Zimmer Biomet | 1 | $22 |
| Dynasplint Systems Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Panta 2$1,911,499
- PANTA NAIL$500,751
- PANTA 2 ARTHRODESIS NAIL SYSTEM$84,923
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$54,679
- TOTAL FOOT SYSTEM$50,798
- CADENCE ANKLE REPLACEMENT SYSTEM$50,798
- STAR$30,750
- ANCHORAGE$15,000
- ASNIS$15,000
- VARIAX$15,000
- HOFFMANN$15,000
- TRIGEN InterTAN$3,881
- Cadence$3,881
- EVOS$3,881
- PANTA$2,340
- HALLU-LOCK$778
- INFINITY$173
- INBONE$129
How this compares
$2,531,170 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $909 |
| Gabapentin | 18 | $316 |
| Ondansetron OdtOndansetron | 30 | $270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $241 |
| Oxycodone Hcl | 22 | $126 |
| Meloxicam | 17 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Dallas
- Richard JonesDallas$6.3M
- Sumant KrishnanDallas$1.9M
- Wayne BurkheadDallas$1.2M
- Bradford WaddellDallas$325K
- Jay MabreyDallas$310K
- Eddie LoDallas$276K
- Clinton BellDallas$261K
- Jesus ReyDallas$227K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.